Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Compugen Ltd. (CGEN : NSDQ)

• Company Description    Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery. Number of Employees: 74

• Price / Volume Information    Yesterday's Closing Price: $1.76 Daily Weekly Monthly 20 Day Moving Average: 596,928 shares Shares Outstanding: 89.24 (millions) Market Capitalization: $157.06 (millions) Beta: 2.61 52 Week High: $2.66 52 Week Low: $1.13 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 23.08% 21.64% 12 Week 18.92% 12.48% Year To Date 15.03% 0.45%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Azrieli Center 26 Harokmim Street Building D - Holon,L3 5885849 ISR ph: 972-3765-8585 fax: 972-3765-8555 ir@cgen.com http://www.cgen.com

• General Corporate Information    Officers Anat Cohen-Dayag - Chief Executive Officer;President and Director Paul Sekhri - Chairman of the Board of Directors David Silberman - Chief Financial Officer Pierre Ferre - Senior Vice President; Preclinical Development and Mathias Hukkelhoven - Director Peer Information Compugen Ltd. (CORR.) Compugen Ltd. (RSPI) Compugen Ltd. (CGXP) Compugen Ltd. (BGEN) Compugen Ltd. (GTBP) Compugen Ltd. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: M25722105 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 89.24 Most Recent Split Date: (:1) Beta: 2.61 Market Capitalization: $157.06 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.34 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.13 Price/Cash Flow: - Price / Sales: 7.09 EPS Growth vs. Year Ago Period: -300.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -81.24% vs. Previous Quarter: -44.96% ROE 09/30/25 - - 06/30/25 - -34.77 03/31/25 - -24.51 ROA 09/30/25 - - 06/30/25 - -16.82 03/31/25 - -12.19 Current Ratio 09/30/25 - - 06/30/25 - 4.74 03/31/25 - 5.09 Quick Ratio 09/30/25 - - 06/30/25 - 4.74 03/31/25 - 5.09 Operating Margin 09/30/25 - - 06/30/25 - -87.45 03/31/25 - -51.27 Net Margin 09/30/25 - - 06/30/25 - -87.45 03/31/25 - -51.27 Pre-Tax Margin 09/30/25 - - 06/30/25 - -67.03 03/31/25 - -34.78 Book Value 09/30/25 - - 06/30/25 - 0.56 03/31/25 - 0.64 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©